Short Interest Update on St. Jude Medical (STJ)

St. Jude Medical (STJ) : The short interest in St. Jude Medical (STJ) has changed with an increase of 976,675 shares and the open interest is 12.4%. From 7,854,486 short positions on Jul 29, 2016, the shorts increased to 8,831,161 shares by August 15, 2016. There are 7 more days left for the expiry and the daily trading volume of the stock is 1,345,380 shares. The total interest of shorts is 3.2% of the shares available to the public. The short interest information was released on Wednesday Aug 24th after the market close.

St. Jude Medical (NYSE:STJ): The stock opened at $82.76 on Wednesday but the bulls could not build on the opening and the stock topped out at $82.90 for the day. The stock traded down to $81.79 during the day, due to lack of any buying support eventually closed down at $81.88 with a loss of -1.05% for the day. The stock had closed at $82.75 on the previous day. The total traded volume was 2,835,459 shares.


In a related news,The officer (VP, Global Quality) of St Jude Medical Inc, Fecho Jeff sold 10,408 shares at $51.71 on February 5, 2016. The Insider selling transaction had a total value worth of $538,198. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.